Analysis of Rex1 (Zfp42) function in embryonic stem cell differentiation

Developmental Dynamics

Volumn 238, Issue 8, 2008, Pages 1863-1877

  Scotland, Kymora B ^a   Chen, Siming ^a,b   Sylvester, Renia ^a,c   Gudas, Lorraine J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Avon Products Inc   (United States)

^c Tissue Genesis Inc   (United States)

Author keywords

Cancer; Cell cycle regulation; Differentiation; Embryoid body; Embryonic stem cell; Knockout; Leukemia inhibitory factor; Microarray; Retinoic acid; Rex1

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; PROTEIN REX1; RETINOIC ACID; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; ECTODERM; EMBRYONIC STEM CELL; ENDODERM; GENE DISRUPTION; GENE EXPRESSION; GENE OVEREXPRESSION; KNOCKOUT GENE; MESODERM; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; BASE SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA PRIMERS; EMBRYONIC STEM CELLS; GENE EXPRESSION; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; TRETINOIN;

MURINAE;

EID: 67650841125     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22037     Document Type: Article

References (64)

1. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-29.
2. Ataliotis P, Symes K, Chou MM, Ho L, Mercola M. 1995. PDGF signalling is required for gastrulation of Xenopus laevis. Development 121:3099-3110.
3. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. 1998. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A 95: 6355-6360.
4. Becker KA, Ghule PN, Therrien JA, Lian JB, Stein JL, van Wijnen AJ, Stein GS. 2006. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol 209: 883-893.
5. Ben-Shushan E, Thompson JR, Gudas LJ, Bergman Y. 1998. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol 18:1866-1878.
6. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956.
7. Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J. 2003. Stem cells. Setting standards for human embryonic stem cells. Science 300:913-916.
8. Chen AC, Gudas LJ. 1996. An analysis of retinoic acid-induced gene expression and metabolism in AB1 embryonic stem cells. J Biol Chem 271:14971-14980.
9. Crettaz M, Baron A, Siegenthaler G, Hunziker W. 1990. Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta. Biochem J 272:391-397.
10. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. 2004. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117:2971-2981.
11. Darr H, Mayshar Y, Benvenisty N. 2006. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 133:1193-1201.
12. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:P3.
13. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87:27-45.
14. Entwistle J, Hall CL, Turley EA. 1996. HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem 61:569-577.
15. Evans MJ, Kaufman MH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
16. Faria TN, Mendelsohn C, Chambon P, Gudas LJ. 1999. The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest. J Biol Chem 274: 26783-26788.
17. Gillespie RF, Gudas LJ. 2007. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. J Mol Biol 372:298-316.
18. Goolsby J, Marty MC, Heletz D, Chiappelli J, Tashko G, Yarnell D, Fishman PS, Dhib-Jalbut S, Bever CT Jr, Pessac B, Trisler D. 2003. Hematopoietic progenitors express neural genes. Proc Natl Acad Sci U S A 100:14926-14931.
19. Gudas LJ. 1994. Retinoids and vertebrate development. J Biol Chem 269:15399-15402.
20. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. 2003. Identifying biological themes within lists of genes with EASE. Genome Biol 4:R70.
21. Hosler BA, LaRosa GJ, Grippo JF, Gudas LJ. 1989. Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol Cell Biol 9:5623-5629.
22. Hosler BA, Rogers MB, Kozak CA, Gudas LJ. 1993. An octamer motif contributes to the expression of the retinoic acidregulated zinc finger gene Rex-1 (Zfp-42) in F9 teratocarcinoma cells. Mol Cell Biol 13:2919-2928.
23. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
24. Kashyap V, Rezende N, Scotland K, Shaffer S, Persson JL,Gudas LJ, Mongan NP. 2009. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the Nanog, OCT4 and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell micro-RNAs. Stem Cells Dev [Epub ahead of print].
25. Kastner P, Krust A, Mendelsohn C, Garnier JM, Zelent A, Leroy P, Staub A, Chambon P. 1990. Murine isoforms of retinoic acid receptor gamma with specific patterns of expression. Proc Natl Acad Sci U S A 87:2700-2704.
26. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, Sasai Y. 2000. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28:31-40.
27. Keller GM. 1995. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 7:862-869.
28. Keller G. 2005. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 19:1129-1155.
29. Langton S, Gudas LJ. 2008. Cyp26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid. Dev Biol 315:331-354.
30. Liu BP, Cafferty WB, Budel SO, Strittmatter SM. 2006. Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci 361:1593-1610.
31. Mangelsdorf DJ, Evans RM. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
32. Marques JT, Williams BR. 2005. Activation of the mammalian immune system by siRNAs. Nat Biotechnol 23:1399-1405.
33. Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78:7634-7638.
34. Martinez-Ceballos E, Chambon P, Gudas LJ. 2005. Differences in gene expression between wild type and Hoxa1 knockout embryonic stem cells after retinoic acid treatment or leukemia inhibitory factor (LIF) removal. J Biol Chem 280:16484-16498.
35. Masui S, Ohtsuka S, Yagi R, Takahashi K, Ko MS, Niwa H. 2008. Rex1/Zfp42 is dispensable for pluripotency in mouse ES cells. BMC Dev Biol 8:45.
36. Mongan NP, Gudas LJ. 2007. Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 75:853-870.
37. Mongan NP, Martin KM, Gudas LJ. 2006. The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol Carcinog 45:887-900.
38. Niwa-Kawakita M, Miyoshi H, Gotoh O, Matsushima Y, Nishimura M, Shisa H, Ohki M. 1995. Cloning and gene mapping of the mouse homologue of the CBFA2T1 gene associated with human acute myeloid leukemia. Genomics 29: 755-759.
39. Osumi N. 2001. The role of Pax6 in brain patterning. Tohoku J Exp Med 193:163-174.
40. Paling NR, Wheadon H, Bone HK, Welham MJ. 2004. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem 279:48063-48070.
41. Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ. 2006. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma. Carcinogenesis 27:499-507.
42. Robertson EJ. 1991. Using embryonic stem cells to introduce mutations into the mouse germ line. Biol Reprod 44:238-245.
43. Rogers MB, Hosler BA, Gudas LJ. 1991. Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development 113:815-824.
44. Rohwedel J, Guan K, Wobus AM. 1999. Induction of cellular differentiation by retinoic acid in vitro. Cells Tissues Organs 165:190-202.
45. Rosfjord E, Rizzino A. 1994. The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells. Biochem Biophys Res Commun 203:1795-1802.
46. Scholz H, Kirschner KM. 2005. A role for the Wilms' tumor protein WT1 in organ development. Physiology (Bethesda) 20: 54-59.
47. Sedding DG, Braun-Dullaeus RC. 2006. Caveolin-1: dual role for proliferation of vascular smooth muscle cells. Trends Cardiovasc Med 16:50-55.
48. Sheibani N, Frazier WA. 1999. Thrombospondin-1, PECAM-1, and regulation of angiogenesis. Histol Histopathol 14: 285-294.
49. Shi W, Wang H, Pan G, Geng Y, Guo Y, Pei D. 2006. Regulation of the pluripotency marker Rex-1 by Nanog and Sox2. J Biol Chem 281:23319-23325.
50. Sledz CA, Williams BR. 2005. RNA interference in biology and disease. Blood 106:787-794.
51. Su D, Gudas LJ. 2008. Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells. Biochem Pharmacol 75:1129-1160.
52. Talbot NC, Rexroad CE Jr, Pursel VG, Powell AM. 1993. Alkaline phosphatase staining of pig and sheep epiblast cells in culture. Mol Reprod Dev 36:139-147.
53. Thompson JR, Gudas LJ. 2002. Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene. Mol Cell Endocrinol 195:119-133.
54. Tighe AP, Gudas LJ. 2004. Retinoic acid inhibits leukemia inhibitory factor signaling pathways in mouse embryonic stem cells. J Cell Physiol 198:223-229.
55. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, Orkin SH. 2006. A protein interaction network for pluripotency of embryonic stem cells. Nature 444:364-368.
56. White J, Dalton S. 2005. Cell cycle control of embryonic stem cells. Stem Cell Rev 1:131-138.
57. Wick W, Platten M, Weller M. 2001. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neurooncol 53:177-185.
58. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM. 1988. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684-687.
59. Wozniak W. 1993. Brain-derived neurotrophic factor (BDNF): role in neuronal development and survival. Folia Morphol (Warsz) 52:173-181.
60. Wu Z, Irizarry RA. 2004. Preprocessing of oligonucleotide array data. Nat Biotechnol 22:656-658.
61. Yang L, Han Y, Suarez Saiz F, Minden MD. 2007. A tumor suppressor and oncogene: the WT1 story. Leukemia 21:868-876.
62. Zandstra PW, Le HV, Daley GQ, Griffith LG, Lauffenburger DA. 2000. Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. Biotechnol Bioeng 69:607-617.
63. Zhang JZ, Gao W, Yang HB, Zhang B, Zhu ZY, Xue YF. 2006a. Screening for genes essential for mouse embryonic stem cell self-renewal using a subtractive RNA interference library. Stem Cells 24:2661-2668.
64. Zhang X, Stojkovic P, Przyborski S, Cooke M, Armstrong L, Lako M, Stojkovic M. 2006b. Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24:2669-2676.